Vimpat and Cefdinir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vimpat (lacosamide) and Cefdinir (cefdinir). Common drug interactions include chronic kidney disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Vimpat and Cefdinir. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Vimpat?

Vimpat has active ingredients of lacosamide. It is often used in epilepsy. eHealthMe is studying from 20,831 Vimpat users. Check the latest studies of Vimpat.

What is Cefdinir?

Cefdinir has active ingredients of cefdinir. It is often used in sinusitis. eHealthMe is studying from 9,210 Cefdinir users. Check the latest studies of Cefdinir.



On Jul, 21, 2026

26 people who take Vimpat and Cefdinir together, and have interactions are studied.

Vimpat and Cefdinir drug interactions.

What are the common drug interactions of Vimpat and Cefdinir, by gender? *:

female:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Anxiety
  4. Pain
  5. Renal hypertension (high blood pressure caused by the kidneys hormonal response)
  6. Arachnoiditis (neuropathic disease caused by inflammation of the arachnoid)
  7. Arthralgia (joint pain)
  8. Back pain
  9. Cervicobrachial syndrome (pain in neck and arm with changing location)
  10. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)

male:

  1. Chronic kidney disease
  2. Pneumonia
  3. Pain
  4. Psoriasis (immune-mediated disease that affects the skin)
  5. Rash
  6. Respiratory failure (inadequate gas exchange by the respiratory system)
  7. Skin discomfort (skin pain/irritation)
  8. Nephrogenic anaemia (anaemia due to kidney disease)
  9. Renal failure (kidney dysfunction)
  10. Adverse event

What are the common drug interactions of Vimpat and Cefdinir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Adverse event
  2. Pneumonia
  3. Respiratory failure (inadequate gas exchange by the respiratory system)

10-19:

  1. Pneumonia

20-29:

n/a

30-39:

  1. Chronic kidney disease
  2. Emotional distress
  3. Osteoporosis (bones weak and more likely to break)
  4. Pain
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Pneumonia
  7. Psoriasis (immune-mediated disease that affects the skin)
  8. Rash
  9. Skin discomfort (skin pain/irritation)

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Renal hypertension (high blood pressure caused by the kidneys hormonal response)
  4. Anxiety
  5. Arachnoiditis (neuropathic disease caused by inflammation of the arachnoid)
  6. Arthralgia (joint pain)
  7. Back pain
  8. Cervicobrachial syndrome (pain in neck and arm with changing location)
  9. Constipation
  10. Dystonia (abnormal muscle tone)

50-59:

  1. Chronic kidney disease
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Renal failure (kidney dysfunction)
  4. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  5. Hospitalisation
  6. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)

60+:

  1. Anxiety
  2. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  3. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  4. Depression
  5. Dysphagia (a condition in which swallowing is difficult or painful)
  6. Failure to thrive (inadequate weight gain and physical growth in children)
  7. Oesophageal injury
  8. Oesophageal stenosis (narrowing of oesophagus)
  9. Renal failure (kidney dysfunction)
  10. Renal injury (kidney injury)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 30.77%
  2. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 7 people, 26.92%
  3. Stress And Anxiety: 6 people, 23.08%
  4. Pain: 6 people, 23.08%
  5. Nausea (feeling of having an urge to vomit): 4 people, 15.38%
  6. Multiple Allergies (allergy to multiple agents): 4 people, 15.38%
  7. Migraine (headache): 4 people, 15.38%
  8. Infection: 4 people, 15.38%
  9. High Blood Cholesterol: 3 people, 11.54%
  10. Bacterial Infection: 3 people, 11.54%

* Approximation only. Some reports may have incomplete information.

Do you take Vimpat and Cefdinir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Vimpat and Cefdinir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vimpat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cefdinir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vimpat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefdinir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lacosamide and cefdinir (the active ingredients of Vimpat and Cefdinir, respectively), and Vimpat and Cefdinir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: